These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2042529)

  • 1. [The effect of topical steroid medication on experimental candida keratitis].
    Isobe Y
    Nippon Ganka Gakkai Zasshi; 1991 Jan; 95(1):45-51. PubMed ID: 2042529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical fluconazole for experimental candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Rüchel R
    Br J Ophthalmol; 1990 Jan; 74(1):40-2. PubMed ID: 2306443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical ketoconazole for experimental Candida keratitis in rabbits.
    Ishibashi Y; Kaufman HE
    Am J Ophthalmol; 1986 Oct; 102(4):522-6. PubMed ID: 3766670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ketoconazole therapy for experimental candida albicans keratitis in rabbits.
    Ishibashi Y; Matsumoto Y
    Sabouraudia; 1984; 22(4):323-30. PubMed ID: 6095470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental candida keratitis. Histological, immunological and electron microscopical studies (author's transl)].
    Mülhäuser J; Wildfeuer A; Meister H; Dybas L; Haferkamp O
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Jul; 195(4):251-62. PubMed ID: 1098511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
    Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T
    Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of K-582, a new antifungal agent, on experimental Candida keratitis.
    Ohno S; Fuerst DJ; Okumoto M; Grabner G; Smolin G
    Invest Ophthalmol Vis Sci; 1983 Dec; 24(12):1626-9. PubMed ID: 6360948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo susceptibility of Candida keratitis to topical polyenes.
    O'Day DM; Ray WA; Robinson RD; Head WS; Savage AM
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):874-80. PubMed ID: 3553060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of Candida albicans keratitis by antilymphocyte serum and corticosteroids.
    Smolin G; Okumoto M
    Am J Ophthalmol; 1969 Oct; 68(4):675-82. PubMed ID: 5344333
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the Effectiveness of Ozone Therapy on the Treatment of Experimentally Induced Keratitis with
    Varol K; Koç AN; Çakır Bayram L; Arda H; Keleş İ; Ünlü M; Güneş V; Ekinci G; Karaca Bekdik İ; Atalay MA
    Semin Ophthalmol; 2022 Feb; 37(2):253-264. PubMed ID: 34693871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental studies of local therapy of Candida keratomycosis with amphotericin B].
    Behrens-Baumann W; Uter W; Ansorg R
    Klin Monbl Augenheilkd; 1987 Aug; 191(2):125-8. PubMed ID: 3669506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The suppressive effect of intravenous fluconazole against endogenous candida endophthalmitis in rabbits].
    Isobe Y; Hatano H
    Nippon Ganka Gakkai Zasshi; 1990 Nov; 94(11):1007-11. PubMed ID: 2075863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous miconazole therapy for experimental keratomycosis in rabbits.
    Ishibashi Y; Matsumoto Y
    Sabouraudia; 1985 Feb; 23(1):55-61. PubMed ID: 3992428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of non-tuberculous mycobacterial keratitis in rabbits].
    Liang QF; Wang ZQ; Deng SJ; Li R; Luo SY; Sun XG
    Zhonghua Yan Ke Za Zhi; 2007 Jul; 43(7):613-7. PubMed ID: 17897550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in response in vivo to amphotericin B among Candida albicans strains.
    O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilymphocyte serum potentiation of candida keratitis.
    Smolin G; Okumoto M
    Am J Ophthalmol; 1968 Nov; 66(5):804-12. PubMed ID: 5686910
    [No Abstract]   [Full Text] [Related]  

  • 18. IL-17 plays a central role in initiating experimental Candida albicans infection in mouse corneas.
    Zhang H; Li H; Li Y; Zou Y; Dong X; Song W; Jia C; Li S; Xi H; Liu D; Wang Y
    Eur J Immunol; 2013 Oct; 43(10):2671-82. PubMed ID: 23843112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of yeast growth phase in vivo on the efficacy of topical polyenes.
    O'Day DM; Ray WA; Robinson RD; Head WS; Savage AM
    Curr Eye Res; 1987 Feb; 6(2):363-8. PubMed ID: 3552454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
    Zhang H; Chen H; Niu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.